Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide for obesity
ChiCTR-TRC-14004996Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Oct 2014
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, open-label trial of liraglutide in obesity (2 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoint: weight. Started Oct 2014; status: recruiting.
02
Drugs
03
Conditions
obesity
Beyond the preview
Go deeper on ChiCTR-TRC-14004996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14004996.